Metabolic
Survodutide
BI 456906 · Glucagon/GLP-1 dual agonist
Glucagon / GLP-1 dual agonist in phase 3 for obesity and MASH.
10 mg
Mazdutide
Also known as: GLP-1/glucagon dual agonist · IBI362 · LY3305677
Metabolic & GLP-1 In stock Box of 10 vials 1 reference
Oxyntomodulin-based GLP-1 / glucagon dual receptor agonist with phase 3 data.
Available sizes
| SKU | Per vial | Pack | |
|---|---|---|---|
| MZ10 | 10 mg | 10 vials / box |
Order Mazdutide
Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.
Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.
Mazdutide is a synthetic analogue of oxyntomodulin that activates both the GLP-1 receptor and the glucagon receptor. Glucagon-receptor activity is associated with increased energy expenditure and hepatic fat reduction in preclinical models.
In the 48-week phase 3 GLORY-1 trial in Chinese adults with obesity or overweight (n = 610), mazdutide 4 mg and 6 mg produced mean weight changes of −10.1% and −12.6% versus 0.5% with placebo 1.
At a glance
- Dual GLP-1 + glucagon receptor agonist
- Phase 3 GLORY-1 published in NEJM (2025)
- 10 mg vials
Research use only. All products are sold strictly for laboratory research and development purposes. They are not intended for human or veterinary use, diagnosis, treatment, cure or prevention of any disease. Not for human consumption. Summaries above describe published findings in laboratory and clinical research models and do not constitute claims about this product.
- Form
- Lyophilized powder
- Purity
- HPLC-verified — Certificate of Analysis available on request
- Pack size
- Box of 10 vials
- Storage
- Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.
- CAS No.
- 2259884-87-8
Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.
- Ji L, Jiang H, Bi Y, et al. Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight. N Engl J Med. 2025;392(22):2215-2225.
Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.
Related
Often ordered together
Metabolic
Retatrutide
GGG triple agonist · LY3437943
Triple GIP / GLP-1 / glucagon receptor agonist — the next generation of incretin research.
5 mg10 mg15 mg20 mg30 mg +4
Metabolic
Semaglutide
GLP-1 receptor agonist · NN9535
Long-acting GLP-1 receptor agonist — the reference compound for incretin-based metabolic research.
5 mg10 mg15 mg20 mg30 mg